Intelligent Bio Solutions annual free cash flow
2024
2025
2026
Intelligent Bio Solutions Free Cash Flow (FCF) History (INBS)
Intelligent Bio Solutions reported −$12.1M in free cash flow for fiscal 2026, a decrease of $2.1M from the previous fiscal year, with a free cash flow margin of −285.94%.
View full Intelligent Bio Solutions company overviewIntelligent Bio Solutions free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2026 | 2026-06-30 | −$12.1M | −$2.1M | — | −285.94% |
| 2025 | 2025-06-30 | −$9.9M | −$116,156 | — | −324.62% |
| 2024 | 2024-06-30 | −$9.8M | — | — | −314.71% |
Intelligent Bio Solutions quarterly free cash flow
Q3.24
Q3.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | −$3.2M | −$412,535 | — | −277.74% |
| Q3 2026 | 2026-03-31 | −$4.3M | −$1.9M | — | −409.45% |
| Q2 2026 | 2025-12-31 | −$1.6M | — | — | −182.40% |
| Q1 2026 | 2025-09-30 | −$2.9M | — | — | −262.39% |
| Q3 2025 | 2025-03-31 | −$2.8M | — | — | −380.01% |
| Q3 2024 | 2024-03-31 | −$2.4M | — | — | −297.29% |
Intelligent Bio Solutions free cash flow growth trends
Intelligent Bio Solutions's latest reported quarter, Q4 2026, generated −$3.2M in free cash flow, a decrease of $412,535 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Intelligent Bio Solutions filings at SEC.gov ↗